GT
VASC

Glenmede Trust’s Vascular Solutions Inc VASC Stock Holding History

Glenmede Trust’s Portfolio VASC Stock Details VASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,219
Closed -$68K – 2836
2016
Q4 		$68K Sell
1,219
-150
-11% -$7.64K ﹤0.01% 1511
2016
Q3 		$66K Sell
1,369
-250
-15% -$11.6K ﹤0.01% 1520
2016
Q2 		$67K Hold
1,619
– – ﹤0.01% 1470
2016
Q1 		$52K Buy
1,619
+225
+16% +$6.49K ﹤0.01% 1508
2015
Q4 		$47K Buy
1,394
+300
+27% +$10.2K ﹤0.01% 1591
2015
Q3 		$35K Hold
1,094
– – ﹤0.01% 1712
2015
Q2 		$37K Hold
1,094
– – ﹤0.01% 1736
2015
Q1 		$33K Buy
1,094
+219
+25% +$6.29K ﹤0.01% 1808
2014
Q4 		$23K Buy
875
+165
+23% +$4.48K ﹤0.01% 1984
2014
Q3 		$17K Buy
+710
New +$16.8K ﹤0.01% 1995

Other funds holding VASC

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Glenmede Trust's VASC Position: Q1 2017 in Review

Glenmede Trust sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 1,219 shares — an estimated $68K sold.

Glenmede Trust first reported a position in VASC in Q3 2014 and held it in 10 quarters. The position peaked at $68K in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Glenmede Trust reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • Glenmede Trust sold 1,219 Vascular Solutions Inc shares in Q1 2017, an estimated $68K.
  • Glenmede Trust first reported a position in Vascular Solutions Inc in Q3 2014 and held it in 10 quarters.
  • Glenmede Trust's Vascular Solutions Inc position peaked at $68K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.